Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
Acta Clin Croat 49(3):257-65 (2010) PMID 21462814
The aim of this work was to determine serum cut-off levels of hyaluronic acid (HA) and laminin (LN) as predicting factors for liver necro-inflammatory injuries, highlighting their diagnostic and therapeutic follow up value in chronic hepatitis B patients. Serum HA and LN were measured in chronic hepatitis B patients (n=35) by ELISA and compared with control group (n=20). Liver histopathologic parameters were evaluated according to the modified Knodell score. The mean serum HA and LN concentrations in patients (108.4 +/- 58.7 and 95.0 +/- 20.1 ng/mL, respectively) were greater than those in controls (46.6 +/- 10.6 and 46.1 +/- 10.2 ng/mL, respectively; P<0.01). The findings suggested the increase in serum HA and LN concentrations above the predictive values (52.0 ng/mL HA and 64.0 ng/mL LN, respectively) to be associated with liver fibrosis. Therefore, serum HA and LN levels could be determined as an additional clinical tool for evaluation of liver fibrosis, when liver biopsy is impossible to perform.
Version: za2963e q8za1 q8zbf q8zc4 q8zd2 q8ze1 q8zf9 q8zg0